News

Scientists have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells.

Election to the Academy is considered one of the highest honors in the fields of health and medicine.

"Because of our aging population, these kinds of therapeutics are in great demand..."

A fascinating new look at fruit fly behavior.

Chemists at Scripps Research have demonstrated that they can repurpose DNA to create new substances with possible medical applications.

The center includes scientists from both the California and Florida campuses of Scripps Research.

Informatics experts at Scripps Research have been awarded close to $3 million as part of a five-year cooperative agreement to launch the National Center for Data to Health (CD2H).

"This new approach shows promise for identifying previously unrecognized ‘druggable’ targets in cancers that lack effective treatments."

The insights could help researchers design new drugs with better efficacy and fewer side effects.

A team of researchers from Scripps Research and Janssen Pharmaceuticals has devised artificial peptide molecules that neutralize a broad range of influenza virus strains.

A new peptide probe may hold the key to better understanding amyloid diseases.

Patrick R. Griffin, co-chair of the Department of Molecular Medicine on the Florida campus of Scripps Research, has been awarded a $2.5 million collaborative grant with Brigham and Women’s Hospital.

"Matt’s scientific contributions and business leadership played an important role in establishing Calibr and creating the new model for translational research and innovation represented by the affiliation with TSRI."

Sugar molecules on HIV envelope protein are likely target for future candidate vaccines.

Scientists at Scripps Research have found a new approach to the “reprogramming” of ordinary adult cells into stem cells.

"We now understand how this complicated assembly process works."

Scientists from the Florida campus of The Scripps Research Institute have identified a class of compounds that significantly delays the onset of several age-related symptoms

"Clearly, there is an urgent need to develop better options for these patients."

One new assistant and one new associate professor to join the institute’s La Jolla and Jupiter campuses, respectively.

Researchers have developed a test that will help scientists identify new drug candidates for treating pain that have fewer side effects, like addiction.

Two new studies led by scientists at Scripps Research could guide future therapies to improve health and lifespan.

"It is one of the most productive large-scale science grants that NIAID funds."

New method provides researchers with a new way to understand such drug compounds, especially where individual components or metabolites interact to produce the complete effects of psychoactive species.

The five-year award provides general, long-term support for research programs that are deemed especially promising.